Superworth

Health Catalyst profit margin HCAT

Gross, operating and net profit as a share of revenue over the last twelve months, from 2018.

Net margin, 12 months
−90.6%
Operating margin, 12 months
−84.4%
Net margin on a year earlier
−58.9 pts
Peer median
6.2%

Over the twelve months to Jun 30, 2026, Health Catalyst kept −90.6% of its revenue as net profit, with an operating margin of −84.4% and a gross margin of 50.5%.

Five years earlier its net margin was −62.3%.

The median for 10 application software stocks of a similar size is 6.2%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025−57.2%−51.7%48.7%
FY2024−22.7%−22.8%45.9%
FY2023−39.9%−42.9%44.5%
FY2022−49.7%−50.7%48.2%
FY2021−63.3%−59.4%48.6%
FY2020−60.9%−50.9%48.1%
FY2019−38.8%−35.4%51.4%
FY2018−55.1%−53.4%46.8%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26−90.6%−58.9 pts−84.4%
Q1 FY26−87.7%−64.4 pts−81.7%
Q4 FY25−57.2%−34.5 pts−51.7%
Q3 FY25−34.1%−7.9 pts−29.2%
Q2 FY25−31.7%−2.8 pts−28.0%
Q1 FY25−23.3%+12.2 pts−21.6%
Q4 FY24−22.7%+17.3 pts−22.8%
Q3 FY24−26.2%+16.4 pts−28.2%
Q2 FY24−28.9%+22.9 pts−32.0%
Q1 FY24−35.6%+17.0 pts−38.7%
Q4 FY23−39.9%+9.8 pts−42.9%
Q3 FY23−42.6%+12.8 pts−45.1%

Against its peers

Companies in Software - Application nearest Health Catalyst's size, closest first, today.

CompanyProfit margin
HCATHealth Catalyst−90.6%
TRAKReposiTrak32.5%
ALISCalisa Acquisitionn/m
EGHT8X80.6%
TZOOTravelzoo0.5%
ZIPZiprecruiter6.2%
OOMAOoma3.6%
CARSCars.com4.7%
IBEXIBEX7.2%
NRDSNerdwallet7.6%
MNTNMNTN18.0%
Peer median6.2%

Where Health Catalyst ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Health Catalyst

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.